Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCI-779 in Androgen-Independent Prostate Cancer
NCT00012142Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Sep 2000; status: completed.
02
Drugs
temsirolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00012142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00012142.